Literature DB >> 18022759

Psychological aspects of multiple sclerosis.

Maria José Sá1.   

Abstract

A significant incidence and prevalence of psychological disorders in multiple sclerosis (MS) has been reported. Their underlying mechanisms and the extent to which they are reactive to psychosocial factors or symptoms of the pathological process itself, remain unclear. Depression is the predominant psychological disturbance with lifetime prevalence around 50% and annual prevalence of 20%. Depression is commoner during relapses, may exacerbate fatigue and cognitive dysfunction and no firm evidence exists of its induction by interferon; instead, treating depression improves adherence to disease-modifying drugs. Anxiety is also frequent, occurs in newly diagnosed patients, and its co-morbidity with depression has been suggested to increase the rate of suicidal ideation. The relationship between stress and MS is an attractive issue because some studies pointed to an association between stressful life-events and MS onset/relapses; however, the evidence supporting this hypothesis is not conclusive so far. Other psychiatric illnesses, as bipolar affective disorder, pathological laughing and crying or psychosis occur less frequently in MS. Therapeutic strategies include psychotherapy, cognitive behavioural therapy, strengthen of coping, and specific medications. The "art" of the MS team in providing the best individualized care is emphasized, aiming to reduce the burden of the disease and improve the patients' quality of life.

Entities:  

Mesh:

Year:  2007        PMID: 18022759     DOI: 10.1016/j.clineuro.2007.10.001

Source DB:  PubMed          Journal:  Clin Neurol Neurosurg        ISSN: 0303-8467            Impact factor:   1.876


  21 in total

Review 1.  Carnitine for fatigue in multiple sclerosis.

Authors:  Aaron M Tejani; Michael Wasdell; Rae Spiwak; Greg Rowell; Shabita Nathwani
Journal:  Cochrane Database Syst Rev       Date:  2012-05-16

2.  Psychopathology in multiple sclerosis: diagnosis, prevalence and treatment.

Authors:  Ida S Haussleiter; Martin Brüne; Georg Juckel
Journal:  Ther Adv Neurol Disord       Date:  2009-01       Impact factor: 6.570

3.  Validation of mood measures for people with multiple sclerosis.

Authors:  Tessa M Watson; Emma Ford; Esme Worthington; Nadina B Lincoln
Journal:  Int J MS Care       Date:  2014

4.  Relationship between disease-modifying therapy and depression in multiple sclerosis.

Authors:  Stephen S Kirzinger; Jason Jones; Angela Siegwald; Andrew Bryce Crush
Journal:  Int J MS Care       Date:  2013

5.  Health-related quality of life outcomes at 1 and 5 years after a residential retreat promoting lifestyle modification for people with multiple sclerosis.

Authors:  Emily J Hadgkiss; George A Jelinek; Tracey J Weiland; Greg Rumbold; Claire A Mackinlay; Siegfried Gutbrod; Ian Gawler
Journal:  Neurol Sci       Date:  2012-02-25       Impact factor: 3.307

6.  A large-scale study of anxiety and depression in people with Multiple Sclerosis: a survey via the web portal of the UK MS Register.

Authors:  Kerina H Jones; David V Ford; Philip A Jones; Ann John; Rodden M Middleton; Hazel Lockhart-Jones; Lisa A Osborne; J Gareth Noble
Journal:  PLoS One       Date:  2012-07-30       Impact factor: 3.240

7.  The Gap in the Current Research on the Link between Health Locus of Control and Multiple Sclerosis: Lessons and Insights from a Systematic Review.

Authors:  Nicola Luigi Bragazzi
Journal:  Mult Scler Int       Date:  2013-02-14

8.  Determinants of sexual dysfunction in women with multiple sclerosis.

Authors:  Khadijeh Mohammadi; Parvin Rahnama; Sakineh Moayed Mohseni; Mohammad Ali Sahraian; Ali Montazeri
Journal:  BMC Neurol       Date:  2013-07-12       Impact factor: 2.474

9.  Diagnostic accuracy for major depression in multiple sclerosis using self-report questionnaires.

Authors:  Anja Fischer; Marcus Fischer; Robert A Nicholls; Stephanie Lau; Jana Poettgen; Kostas Patas; Christoph Heesen; Stefan M Gold
Journal:  Brain Behav       Date:  2015-07-14       Impact factor: 2.708

10.  Longitudinal study of alexithymia and multiple sclerosis.

Authors:  Khadija Chahraoui; Céline Duchene; Fabien Rollot; Bernard Bonin; Thibault Moreau
Journal:  Brain Behav       Date:  2013-12-18       Impact factor: 2.708

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.